相关实验视频

Updated: Jun 15, 2026

Reduction of Radiation Exposure during Endovascular Treatment of Peripheral Arterial Disease Combining Fiber Optic RealShape Technology and Intravascular Ultrasound

Reduction of Radiation Exposure during Endovascular Treatment of Peripheral Arterial Disease Combining Fiber Optic RealShape Technology and Intravascular Ultrasound

Published on: April 21, 2023

关于Advanta V12/iCast作为Iliac分支器件中的桥梁支架的系统审查和元分析结果

George Apostolidis¹, Konstantinos Dakis², José I Torrealba¹

¹German Aortic Centre, Department of Vascular Medicine, University Heart and Vascular Centre UKE Hamburg, Hamburg, Germany.

Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists

|January 7, 2026

概括

阿德瓦达V12/iCast桥梁支架在阴茎分支器件手术中表现出高的技术成功率 (98%) 和低的并发症率. 这一元分析表明,它是保留内动脉输液的可靠选择.

科学领域:

血管外科血管外科
干预性放射学干预性放射学
医疗器械技术医疗器械技术

背景情况:

阴道分支器件 (IBD) 对于维持内阴道动脉 (IIA) 输液至关重要.
有限的数据存在于IBD程序的最佳桥梁支架选择.

研究的目的:

评估Advanta V12/iCast支架在IBD手术中作为桥梁支架使用时的结果.
评估技术成功率,狭窄/封闭率,内皮泄漏率和重新干预率.

主要方法:

在PubMed,Scopus和Cochrane图书馆的系统文献搜索.
包括10项观察性研究 (2000-2025年) 与467个桥接的IIA.
主要结果的比例元分析,包括偏差风险和证据质量评估 (ROBINS-I,GRADE).

主要成果:

对于Advanta V12/iCast,技术成功率高达98%.
30天的低率:闭塞/缩水 (2%),内孔 Ic/IIIc (0.3%),重新干预 (1%).
较低的随访率:闭塞/缩小 (4%),内漏 Ic/IIIc (5%),重复干预 (5%),平均时间为23.4个月.

结论:

Advanta V12/iCast显示了有利的结果,表明可靠性作为IBD的桥梁支架.
低阻塞/狭窄,内和重新干预率支持其使用.
低质量的证据需要谨慎地解释结果.

关键词:

优点 V12 的优点在 iCast 里面,你会看到 iCast.阴茎分支器件阴茎分支器件支架是一种支架.目标船只的目标船只

相关概念视频

Cable Subjected to a Distributed Load

Cable Subjected to a Distributed Load

The analysis of suspension bridges is a complex and critical process that involves multiple factors, including the shape and tension of the main cables. The main cables of suspension bridges are subjected to distributed loads, which result in changes in tensile forces and deformation of the cable. These loads must be carefully considered to ensure that the bridge is safe and capable of supporting the weight of different loads.